MARINEMAX INC (HZO) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:HZO - US5679081084 - Common Stock
28.82 USD
-0.11 (-0.38%)
28.82 USD
0 (0%)
We assign a fundamental rating of 3 out of 10 to HZO. HZO was compared to 121 industry peers in the Specialty Retail industry. HZO has a bad profitability rating. Also its financial health evaluation is rather negative. HZO is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- HZO had positive earnings in the past year.
- HZO had a positive operating cash flow in the past year.
- Of the past 5 years HZO 4 years were profitable.
- In multiple years HZO reported negative operating cash flow during the last 5 years.
1.2 Ratios
- The Return On Assets of HZO (-1.28%) is comparable to the rest of the industry.
- The Return On Equity of HZO (-3.38%) is comparable to the rest of the industry.
- The Return On Invested Capital of HZO (3.34%) is comparable to the rest of the industry.
- Measured over the past 3 years, the Average Return On Invested Capital for HZO is significantly below the industry average of 12.37%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.28% | ||
| ROE | -3.38% | ||
| ROIC | 3.34% |
ROA(3y)1.56%
ROA(5y)6.94%
ROE(3y)4.15%
ROE(5y)12.76%
ROIC(3y)4.73%
ROIC(5y)10.19%
1.3 Margins
- The Operating Margin of HZO (4.46%) is better than 63.11% of its industry peers.
- HZO's Operating Margin has declined in the last couple of years.
- With a Gross Margin value of 32.49%, HZO is not doing good in the industry: 61.48% of the companies in the same industry are doing better.
- HZO's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.46% | ||
| PM (TTM) | N/A | ||
| GM | 32.49% |
OM growth 3Y-27.03%
OM growth 5Y-9.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.37%
GM growth 5Y4.23%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HZO is destroying value.
- HZO has less shares outstanding than it did 1 year ago.
- Compared to 5 years ago, HZO has about the same amount of shares outstanding.
- HZO has a worse debt/assets ratio than last year.
2.2 Solvency
- HZO has an Altman-Z score of 1.84. This is not the best score and indicates that HZO is in the grey zone with still only limited risk for bankruptcy at the moment.
- HZO has a Altman-Z score of 1.84. This is comparable to the rest of the industry: HZO outperforms 44.26% of its industry peers.
- HZO has a debt to FCF ratio of 92.74. This is a negative value and a sign of low solvency as HZO would need 92.74 years to pay back of all of its debts.
- The Debt to FCF ratio of HZO (92.74) is comparable to the rest of the industry.
- HZO has a Debt/Equity ratio of 1.14. This is a high value indicating a heavy dependency on external financing.
- With a Debt to Equity ratio value of 1.14, HZO perfoms like the industry average, outperforming 40.98% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.14 | ||
| Debt/FCF | 92.74 | ||
| Altman-Z | 1.84 |
ROIC/WACC0.37
WACC8.94%
2.3 Liquidity
- A Current Ratio of 1.20 indicates that HZO should not have too much problems paying its short term obligations.
- With a Current ratio value of 1.20, HZO perfoms like the industry average, outperforming 40.16% of the companies in the same industry.
- HZO has a Quick Ratio of 1.20. This is a bad value and indicates that HZO is not financially healthy enough and could expect problems in meeting its short term obligations.
- HZO has a worse Quick ratio (0.32) than 68.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.2 | ||
| Quick Ratio | 0.32 |
3. Growth
3.1 Past
- HZO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -59.91%.
- Measured over the past years, HZO shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -24.26% on average per year.
- The Revenue has decreased by -5.01% in the past year.
- Measured over the past years, HZO shows a quite strong growth in Revenue. The Revenue has been growing by 8.87% on average per year.
EPS 1Y (TTM)-59.91%
EPS 3Y-54.22%
EPS 5Y-24.26%
EPS Q2Q%-116.67%
Revenue 1Y (TTM)-5.01%
Revenue growth 3Y0.02%
Revenue growth 5Y8.87%
Sales Q2Q%-1.95%
3.2 Future
- Based on estimates for the next years, HZO will show a very strong growth in Earnings Per Share. The EPS will grow by 50.07% on average per year.
- HZO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.37% yearly.
EPS Next Y5.9%
EPS Next 2Y39.26%
EPS Next 3Y50.07%
EPS Next 5YN/A
Revenue Next Year1.95%
Revenue Next 2Y2.98%
Revenue Next 3Y3.37%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 33.91, which means the current valuation is very expensive for HZO.
- HZO's Price/Earnings ratio is in line with the industry average.
- The average S&P500 Price/Earnings ratio is at 27.38. HZO is valued slightly more expensive when compared to this.
- Based on the Price/Forward Earnings ratio of 32.02, the valuation of HZO can be described as expensive.
- The rest of the industry has a similar Price/Forward Earnings ratio as HZO.
- HZO is valuated rather expensively when we compare the Price/Forward Earnings ratio to 24.29, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.91 | ||
| Fwd PE | 32.02 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, HZO is valued cheaply inside the industry as 86.89% of the companies are valued more expensively.
- HZO's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 52.78 | ||
| EV/EBITDA | 5.59 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- A more expensive valuation may be justified as HZO's earnings are expected to grow with 50.07% in the coming years.
PEG (NY)5.75
PEG (5Y)N/A
EPS Next 2Y39.26%
EPS Next 3Y50.07%
5. Dividend
5.1 Amount
- No dividends for HZO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
28.82
-0.11 (-0.38%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-13 2025-11-13/bmo
Earnings (Next)01-22 2026-01-22
Inst Owners97.97%
Inst Owner Change0.08%
Ins Owners2.85%
Ins Owner Change9.65%
Market Cap630.29M
Revenue(TTM)2.31B
Net Income(TTM)-31.63M
Analysts81.54
Price Target31.47 (9.2%)
Short Float %22.26%
Short Ratio13.22
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.75%
Min EPS beat(2)-59.12%
Max EPS beat(2)68.62%
EPS beat(4)3
Avg EPS beat(4)70.61%
Min EPS beat(4)-59.12%
Max EPS beat(4)189.48%
EPS beat(8)4
Avg EPS beat(8)16.56%
EPS beat(12)5
Avg EPS beat(12)7.14%
EPS beat(16)9
Avg EPS beat(16)12.31%
Revenue beat(2)1
Avg Revenue beat(2)-4.93%
Min Revenue beat(2)-12.47%
Max Revenue beat(2)2.61%
Revenue beat(4)2
Avg Revenue beat(4)-1.55%
Min Revenue beat(4)-12.47%
Max Revenue beat(4)8.06%
Revenue beat(8)4
Avg Revenue beat(8)-1.17%
Revenue beat(12)6
Avg Revenue beat(12)0.01%
Revenue beat(16)9
Avg Revenue beat(16)0.51%
PT rev (1m)0%
PT rev (3m)-9.69%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-134.17%
EPS NY rev (1m)-4.61%
EPS NY rev (3m)-51.94%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.98%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-1.79%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.91 | ||
| Fwd PE | 32.02 | ||
| P/S | 0.27 | ||
| P/FCF | 52.78 | ||
| P/OCF | 8.66 | ||
| P/B | 0.67 | ||
| P/tB | 1.68 | ||
| EV/EBITDA | 5.59 |
EPS(TTM)0.85
EY2.95%
EPS(NY)0.9
Fwd EY3.12%
FCF(TTM)0.55
FCFY1.89%
OCF(TTM)3.33
OCFY11.55%
SpS105.59
BVpS42.85
TBVpS17.14
PEG (NY)5.75
PEG (5Y)N/A
Graham Number28.63
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.28% | ||
| ROE | -3.38% | ||
| ROCE | 6.94% | ||
| ROIC | 3.34% | ||
| ROICexc | 3.62% | ||
| ROICexgc | 5% | ||
| OM | 4.46% | ||
| PM (TTM) | N/A | ||
| GM | 32.49% | ||
| FCFM | 0.52% |
ROA(3y)1.56%
ROA(5y)6.94%
ROE(3y)4.15%
ROE(5y)12.76%
ROIC(3y)4.73%
ROIC(5y)10.19%
ROICexc(3y)5.21%
ROICexc(5y)12.96%
ROICexgc(3y)7.5%
ROICexgc(5y)19.19%
ROCE(3y)9.35%
ROCE(5y)16.79%
ROICexgc growth 3Y-45.93%
ROICexgc growth 5Y-23.4%
ROICexc growth 3Y-45.55%
ROICexc growth 5Y-25.45%
OM growth 3Y-27.03%
OM growth 5Y-9.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.37%
GM growth 5Y4.23%
F-Score5
Asset Turnover0.93
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.14 | ||
| Debt/FCF | 92.74 | ||
| Debt/EBITDA | 7.03 | ||
| Cap/Depr | 123.41% | ||
| Cap/Sales | 2.64% | ||
| Interest Coverage | 1.33 | ||
| Cash Conversion | 47.78% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.2 | ||
| Quick Ratio | 0.32 | ||
| Altman-Z | 1.84 |
F-Score5
WACC8.94%
ROIC/WACC0.37
Cap/Depr(3y)139.54%
Cap/Depr(5y)177.5%
Cap/Sales(3y)2.62%
Cap/Sales(5y)2.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-59.91%
EPS 3Y-54.22%
EPS 5Y-24.26%
EPS Q2Q%-116.67%
EPS Next Y5.9%
EPS Next 2Y39.26%
EPS Next 3Y50.07%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.01%
Revenue growth 3Y0.02%
Revenue growth 5Y8.87%
Sales Q2Q%-1.95%
Revenue Next Year1.95%
Revenue Next 2Y2.98%
Revenue Next 3Y3.37%
Revenue Next 5YN/A
EBIT growth 1Y-19.62%
EBIT growth 3Y-27.02%
EBIT growth 5Y-1%
EBIT Next Year25.8%
EBIT Next 3Y19.63%
EBIT Next 5YN/A
FCF growth 1Y113.87%
FCF growth 3Y-12.94%
FCF growth 5Y-47.23%
OCF growth 1Y383.73%
OCF growth 3Y-1.68%
OCF growth 5Y-24.9%
MARINEMAX INC / HZO FAQ
Can you provide the ChartMill fundamental rating for MARINEMAX INC?
ChartMill assigns a fundamental rating of 3 / 10 to HZO.
What is the valuation status of MARINEMAX INC (HZO) stock?
ChartMill assigns a valuation rating of 3 / 10 to MARINEMAX INC (HZO). This can be considered as Overvalued.
Can you provide the profitability details for MARINEMAX INC?
MARINEMAX INC (HZO) has a profitability rating of 3 / 10.
Can you provide the financial health for HZO stock?
The financial health rating of MARINEMAX INC (HZO) is 3 / 10.